A fusion of CD63–BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis

BACKGROUND: Recently, fusion variants of the breast cancer anti-oestrogen-resistance 4 (BCAR4) gene were recurrently discovered in lung adenocarcinoma from the genome-wide studies. However, the functional characterisation of BCAR4 fusion has not been investigated. METHODS: Based on the analysis of R...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Kieun, Kim, Jin Hee, Jung, Hyojik, Kong, Sun-Young, Kim, Yun-Hee, Kim, Sunshin, Lee, Geon Kook, Lee, Jin Soo, Lee, Jake June-Koo, Ju, Young Seok, Choi, Yang-Kyu, Yoon, Kyong-Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782829/
https://www.ncbi.nlm.nih.gov/pubmed/33204025
http://dx.doi.org/10.1038/s41416-020-01146-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782829/
https://www.ncbi.nlm.nih.gov/pubmed/33204025
http://dx.doi.org/10.1038/s41416-020-01146-3

Ejemplares similares